Taiwan FDA registration 09d56f8e2f74f66bd60683aa716279fc
"Bidi" Phoenix Gram Identification and Drug Susceptibility Test-30
TW: "必帝" Phoenix 革蘭氏菌鑑定及藥物敏感性測試劑-30
Taiwan·Risk Class 2·BECTON, DICKINSON AND COMPANY (BD)·Registered Apr 17, 2006 – Apr 17, 2021CancelledRegistration details
- Analysis ID
- 09d56f8e2f74f66bd60683aa716279fc
- Customs Code
- DHA00601636500
Company information
- Manufacturer
- BECTON, DICKINSON AND COMPANY (BD)
- Manufacturer Country
- United States
- Authorized Representative
- BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)
Product details
- Intended Use
- Rapid identification and drug susceptibility testing of most Gram-negative aerobic and facultative anaerobic bacteria of human origin.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.1640 抗菌感受性試驗粉末
- Import Information
- import
Dates and status
- Registration Date
- Apr 17, 2006
- Expiry Date
- Apr 17, 2021
- Cancellation Date
- Sep 08, 2023
Cancellation information
- Status
- Logged out
- Reason
- 未展延而逾期者
About this record
Access comprehensive regulatory information for "Bidi" Phoenix Gram Identification and Drug Susceptibility Test-30 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 09d56f8e2f74f66bd60683aa716279fc and manufactured by BECTON, DICKINSON AND COMPANY (BD). The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices